Jiangsu HengRui Medicine Co., Ltd.: all 1,057 studies

Page 7 of 11. Open to participants first (303), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Efficacy and Safety of HR18042 Tablets for Postoperative Analgesia After Impacted Teeth Removal Surgery.TerminatedNCT05470075Phase 2
• A Clinical Study of the Combination of SHR8554 Injection and SHR0410 Injection for the Treatment of Pain After Abdominal Surgery.Status unknownNCT05470049Phase 2
• Study of HR20013 for Injection in Patients With Malignant Solid TumorsCompletedNCT05465681Phase 1
• A Study of HR19024 in Subjects With Advanced Solid TumorCompletedNCT05463432Phase 1
• A Trial of SHR0410 Injection for the Treatment of Pain After Laparoscopic SurgeryStatus unknownNCT05459220Phase 3
• A Study of Food Effect on the Pharmacokinetics of Fuzuloparib Capsules in Chinese Healthy Adult SubjectsCompletedNCT05440006Phase 1
• Safety and Tolerability of SHR-1918 in Healthy SubjectsActive, not recruitingNCT05432544Phase 1
• A Phase II Study of HR070803 in the Treatment of Advanced Esophageal CancerStatus unknownNCT05425472Phase 2
• A Trial of SHR-A1811versus Pyrotinib in Combination With Capecitabine in HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and TaxaneActive, not recruitingNCT05424835Phase 3
• Study of the Bioequivalence and Food Effects of HRX0701 Tablets in Healthy SubjectsCompletedNCT05415644Phase 1
• Study on the Pharmacokinetic Effect of Itraconazole on SHR0302 Tablets in Healthy SubjectsCompletedNCT05404724Phase 1
• A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Pharmacodynamics of SHR-2010 by Intravenously/Subcutaneously in Healthy SubjectCompletedNCT05398510Phase 1
• Efficacy and Safety of SHR-1314 by Subcutaneous Injection in Active Moderate to Severe Graves' Orbitopathy PatientsTerminatedNCT05394857Phase 2
• The Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid TumorsCompletedNCT05394818Phase 1
• A Trial of SHR0410 Injection in Postsurgical Pain ManagementTerminatedNCT05394402Phase 2
• A Pharmacokinetic Study to Evaluate the Drug Interaction Between SHR0302 and CYP Substrates in Healthy VolunteersCompletedNCT05392127Phase 1
• A Trial of HR18034 for Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy.CompletedNCT05376904Phase 2
• A Study of SHR8554 Injection for the Treatment of Pain After Orthopedic SurgeryCompletedNCT05375305Phase 2/3
• Study of Bioavailability, Pharmacodynamics and Safety of SHR-1209 Administered by Single Subcutaneous Injection at Different Sites in Healthy VolunteersCompletedNCT05370950Phase 1
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single-dose Injection of SHR-2004 in Healthy SubjectsStatus unknownNCT05369767Phase 1
• A Study to Evaluate Camrelizumab Plus Rivoceranib (Apatinib) Versus Camrelizumab as Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or AblationCompletedNCT05367687Phase 2
• Phase I Study of HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple MyelomaActive, not recruitingNCT05363800Phase 1
• A Phase Ib/II Study of SHR-A1811 Injection in Breast CancerStatus unknownNCT05353361Phase 2
• A Phase I Single- and Multiple- Ascending Dose and Food Effect Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-7535 in Healthy SubjectsStatus unknownNCT05347758Phase 1
• A Trial of HR091506 Tablets in Treatment of Primary Gout With Hyperuricemia in AdultsStatus unknownNCT05347498Phase 1
• Bioequivalence Study of Famitinib Malate in Healthy Volunteers Under Fasting ConditionCompletedNCT05336279Phase 1
• The Relative Bioavailability of INS068 Injection With Two Different Formulations in Healthy SubjectsCompletedNCT05336071Phase 1
• A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 DiabetesStatus unknownNCT05333835Phase 2
• Single Ascending Dose and Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-1816 in Healthy SubjectsTerminatedNCT05330208Phase 1
• A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Non-Radiographic Axial SpondyloarthritisStatus unknownNCT05324631Phase 3
• A Study of TACE Combined With Camrelizumab Plus Rivoceranib (Apatinib) in Patients With Incurable Hepatocellular CarcinomaActive, not recruitingNCT05320692Phase 3
• A Study to Evaluate the Efficacy and Safety of HRS4800 Tablets for Postoperative Analgesia After Impacted Teeth Removal Surgery.CompletedNCT05318846Phase 2
• A Study of HRS7415 Tablets in Patients With Advanced Malignant TumorsCompletedNCT05318833Phase 1
• A Trial of HR17031 Injection With Renal InsufficiencyCompletedNCT05292495Phase 1
• A Trial of HRS-2261 in Healthy Subjects After Single and Multiple Oral AdministrationCompletedNCT05274516Phase 1
• A Pharmacokinetic Study to Evaluate the Drug Interaction Between HRS5091 and Probe Drugs in Healthy VolunteersCompletedNCT05273775Phase 1
• A Clinical Study of Hetrombopag Olamine Tablets in Adults Receiving 21-day Cycles of Chemotherapy for Solid Tumours, Who Are Delayed for at Least 1 Week From Their Scheduled Cycle Because of Chemotherapy-induced ThrombocytopeniaWithdrawnNCT05261646Phase 3
• A Non-interventional Study of Remazolam Methyl Benzene Sulfonic Acid for Injection in Real-world Clinical PracticeCompletedNCT05254366
• Effect of Montmorillonite Power or Loperamide on the Pharmacokinetics of Pyrotinib in Healthy SubjectsCompletedNCT05252546Phase 1
• A Trial of SHR6508 in Secondary HyperparathyroidismCompletedNCT05221008Phase 1
• A Trial of Camrelizumab for Injection in Combination With Famitinib Malate Capsule and Paclitaxel For Injection(Albumin Bound) in Advanced Solid Tumors of PatientsStatus unknownNCT05214976Phase 2
• A Study of SHR-1802 in Patients With Advanced Solid TumorTerminatedNCT05208177Phase 2
• Clinical Study on the Efficacy and Safety of Multiple Oral Administrations of SHR2285 Tablets in Patients Undergoing Elective Total Knee ArthroplastyTerminatedNCT05203705Phase 2
• A Trial of SHR-2002 Injection or Combined With Other Anti-cancer Medication in Advanced Malignant Tumors of PatientsStatus unknownNCT05198817Phase 1
• A STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF MULTIPLE SUBCUTANEOUS INJECTIONS OF SHR-1819 IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITISCompletedNCT05197023Phase 1
• A Clinical Study of the Safety and Tolerability of SHR-1901 in Subjects With Advanced Malignant TumorsCompletedNCT05193721Phase 1
• A Study of SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical CancerTerminatedNCT05179239Phase 3
• To Compare the Efficacy and Safety of BP102 vs. Avastin® in Combination With Paclitaxel/Carboplatin in First-line Treatment of Advanced or Relapsed NSCLCCompletedNCT05169801Phase 3
• A Study of SHR-A1909 in Subjects With Advanced Malignant TumorsCompletedNCT05162469Phase 1
• A Study of SHR-A1921 for Injection in Subjects With Advanced Solid TumoursStatus unknownNCT05154604Phase 1
• A Study of Remimazolam Tosilate for Sedation in the ICUCompletedNCT05152303Phase 2
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS9531 in Healthy SubjectsCompletedNCT05152277Phase 1
• A Trial of HR17031 Injection With Hepatic InsufficiencyStatus unknownNCT05151705Phase 1
• Clinical Study of SHR-1701 Plus Chemotherapy as Perioperative Treatment in Subjects With Gastric CancerTerminatedNCT05149807Phase 2/3
• Drug-drug Interaction Study Between Fluconazole and Famitinib in Healthy SubjectsCompletedNCT05147727Phase 1
• A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HR011408 at Two Formulations in Healthy SubjectCompletedNCT05147259Phase 1
• A First-in-human Study of HRS2398 Tablets in Subjects With Advanced Malignant TumorsCompletedNCT05144061Phase 1
• A Drug-drug Interaction Study of SHR2150 on Healthy Chinese VolunteersStatus unknownNCT05141422Phase 1
• Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous NephropathyActive, not recruitingNCT05136456Phase 2
• A Study of Camrelizumab in Combination With Chemotherapy Regimen Comparative Chemotherapy Regimen for Metastatic Triple-negative Breast CancerTerminatedNCT05134194Phase 3
• A Study of SHR-1701 Plus Bevacizumab and Chemotherapy in Non-Small-Cell-Lung-CancerStatus unknownNCT05132413Phase 3
• A Study to Assess the Effect of Food on HR20033 and Pharmacokinetic After Multiple Dose in Healthy VolunteersStatus unknownNCT05120219Phase 1
• A Phase I Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid TumorsActive, not recruitingNCT05114759Phase 1
• A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of ChildrenCompletedNCT05111431Phase 3
• A Study to Assess the Bioequivalence of Fixed Dose Combination of HR20033 Relative to Co-administration of the Individual Components in Healthy Chinese SubjectsStatus unknownNCT05108350Phase 1
• A Study to Evaluate Camrelizumab Combined With Famitinib as Subsequent Therapy in Patients With Advanced NSCLCTerminatedNCT05106335Phase 3
• A Study of SHR6390 Combined With Famitinib in the Treatment of ER + / HER2- Advanced Breast CancerTerminatedNCT05103826Phase 1
• Study to Evaluate the Mass Balance and Biotransformation of [14C]SHR1459 in Healthy Adult Male VolunteersStatus unknownNCT05095337Phase 1
• A Bioequivalence Study of Hetrombopag in Healthy SubjectsCompletedNCT05088655Phase 1
• A Trial of Hetrombopag in Healthy and Hepatic Impairment SubjectsCompletedNCT05088642Phase 1
• Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy SubjectsCompletedNCT05088343Phase 1
• A Trial of Hetrombopag in Healthy SubjectsCompletedNCT05088174Phase 1
• A Study of Irinotecan Hydrochloride Liposome in Combination With 5-FU/LV in Advanced Solid TumorsCompletedNCT05086848Phase 1
• A Study of Irinotecan Hydrochloride Liposome in Advanced Solid TumorsCompletedNCT05086822Phase 1
• Phase I Study of SHR-2002 + SHR-1316 in Patients With Advanced Malignant TumorsCompletedNCT05082545Phase 1
• Identify Effective Doses of SHR7280 Tablets in Controlled Ovarian Hyperstimulation (COH) for Female Subjects Undergoing Assisted Reproductive Technology (ART)CompletedNCT05082233Phase 2
• A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Recurrent Vulvovaginal CandidiasisStatus unknownNCT05074602Phase 3
• Irinotecan Liposome in Combination With 5-FU/LV Versus 5-FU/LV in Second-line Therapy for Gemcitabine-Refractory Pancreatic CancerCompletedNCT05074589Phase 3
• A Study of HRS2543 in Patients With Advanced TumorsTerminatedNCT05068856Phase 1
• Study of the Effectiveness and Safety of SHR-1314 for Psoriatic ArthritisCompletedNCT05055934Phase 2
• Clinical Study of Retagliptin Phosphate Combined With Metformin in the Treatment of Type 2 DiabetesActive, not recruitingNCT05054842Phase 3
• A Relative Bioavailability Study of Different Processes of SHR2554 Tablets in Healthy Adult SubjectsStatus unknownNCT05049083Phase 1
• A Phase I Study of HRS2300 or Combined With SHR-1316 or SHR-1701 or Trametinib or Almonertinib in Patients With Advanced MalignanciesTerminatedNCT05048134Phase 1
• A Study of Human Substance Balance and Biotransformation of [14C]SHR0302CompletedNCT05047341Phase 1
• Pharmacokinetics Study of Famitinib Malate Capsules in Healthy SubjectsCompletedNCT05046808Phase 1
• A Trial of SHR-1703 in AsthmaStatus unknownNCT05042401Phase 1
• A Drug-drug Interaction Study of Famitinib Malate With a Proton Pump Inhibitor in Healthy Adult SubjectsCompletedNCT05041920Phase 1
• Safety and Pharmacokinetics of Fluzoparib in Healthy Subjects and Those With Impaired Kidney FunctionCompletedNCT05032235Phase 1
• Pharmacokinetics of HR17031 Injection in Healthy SubjectsCompletedNCT05031871Phase 1
• SHR-1701 in Combination With Famitinib in Patients With Recurrent/Metastatic Nasopharyngeal CarcinomaStatus unknownNCT05020925Phase 1/2
• A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Primary IgA Nephropathy.CompletedNCT05016323Phase 2
• A Trial of Efficacy and Safety of Remimazolam Tosilate for Injection in Local Anesthesia Assisted SedationCompletedNCT05015361Phase 2
• A Trial of SHR3680 in Prostate Cancer Patients Who Are Candidates for Radical ProstatectomyTerminatedNCT05009290Phase 3
• A Phase 1 Dose Escalation and Expansion Study Of SHR7280 In Subjects With Hormone Sensitive Prostate CancerCompletedNCT04995042Phase 1
• A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary HyperparathyroidismStatus unknownNCT04994080Phase 3
• A Phase 1 Study of HRS8807 Monotherapy and in Combination With SHR6390 in Subjects With ER-Positive, HER2-Negative Metastatic or Locally Advanced Breast CancerActive, not recruitingNCT04993430Phase 1
• A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics of HRS4800 in Healthy SubjectsStatus unknownNCT04991909Phase 1
• Effect of Omeprazole on the Pharmacokinetics of SHR6390 in Healthy SubjectsCompletedNCT04989829Phase 1
• A Trial of SHR - 1906 in Healthy SubjectsCompletedNCT04986540Phase 1
• A Study of Camrelizumab Combined With Rivoceranib Mesylate Versus Investigator's Choice of Regimen in Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)TerminatedNCT04985136Phase 3

← Jiangsu HengRui Medicine Co., Ltd. overview and focus areas